These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 531127)
1. [Psychopharmacology and endorphins]. Langwiński R Psychiatr Pol; 1979; 13(6):533-42. PubMed ID: 531127 [No Abstract] [Full Text] [Related]
2. [The significance of endorphins and gamma-aminobutyric acid in clinical psychopharmacology (author's transl)]. Vinar O Cesk Psychiatr; 1978 Apr; 74(2):98-107. PubMed ID: 357024 [No Abstract] [Full Text] [Related]
3. Research in endorphins and schizophrenia. Davis GC; Buchsbaum MS; Bunney WE Schizophr Bull; 1979; 5(2):244-50. PubMed ID: 37596 [TBL] [Abstract][Full Text] [Related]
4. Some observations on the opiate peptides and schizophrenia. Watson SJ; Akil H; Berger PA; Barchas JD Arch Gen Psychiatry; 1979 Jan; 36(1):35-41. PubMed ID: 216330 [TBL] [Abstract][Full Text] [Related]
6. Endorphin hypothesis of schizophrenia. Wahlström A; Terenius L Mod Probl Pharmacopsychiatry; 1981; 17():181-91. PubMed ID: 6276723 [No Abstract] [Full Text] [Related]
7. [Etiologic and therapeutic significance of endorphins in endogenous psychoses]. Naber D Nervenarzt; 1983 Nov; 54(11):573-7. PubMed ID: 6318141 [No Abstract] [Full Text] [Related]
8. [Endogenous opioids and gamma type endorphins in schizophrenia]. Verhoeven WM Arch Neurobiol (Madr); 1983; 46(5):335-8. PubMed ID: 6362599 [No Abstract] [Full Text] [Related]
9. Psychopharmacology of morphinomimetic peptides in relation to schizophrenia. Malek-Ahmadi P Gen Pharmacol; 1978; 9(4):221-2. PubMed ID: 680554 [No Abstract] [Full Text] [Related]
10. Biochemistry and the schizophrenia. Old concepts and new hypothesis. Berger PA J Nerv Ment Dis; 1981 Feb; 169(2):90-9. PubMed ID: 7009786 [TBL] [Abstract][Full Text] [Related]
11. Endorphins: naloxone failure to increase sexual arousal in sexually unresponsive women: a preliminary report. Brady JP; Bianco CF Biol Psychiatry; 1980 Aug; 15(4):627-31. PubMed ID: 6249406 [No Abstract] [Full Text] [Related]
12. Opioid agonists and antagonists in schizophrenia. Barchas JD; Berger PA; Watson SJ; Akil H; Li CH Adv Biochem Psychopharmacol; 1980; 22():447-53. PubMed ID: 7395601 [No Abstract] [Full Text] [Related]
13. Neuropeptides, dopamine, and schizophrenia. Nemeroff CB; Bissette G Ann N Y Acad Sci; 1988; 537():273-91. PubMed ID: 3059929 [No Abstract] [Full Text] [Related]
14. Endorphins in shock and spinal injury; therapeutic effects of naloxone and thyrotropin-releasing hormone. Holaday JW Prog Clin Biol Res; 1983; 111():167-84. PubMed ID: 6306678 [No Abstract] [Full Text] [Related]
15. Binding sites for non-opioid gamma-type endorphins in brain structures of the mesocorticolimbic feedback circuit. Wiegant VM; Ronken E; de Boer T; Tonnaer JA Prog Clin Biol Res; 1990; 328():29-32. PubMed ID: 1689494 [No Abstract] [Full Text] [Related]
16. [Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases]. Bakharev VD; Tikhomirov SM Sov Med; 1984; (6):50-3. PubMed ID: 6147020 [No Abstract] [Full Text] [Related]
17. Naloxone in schizophrenia. Pickar D Lancet; 1983 Apr; 1(8328):819. PubMed ID: 6132151 [No Abstract] [Full Text] [Related]
18. Isolation and characterization of in vitro central beta-endorphin metabolism in schizophrenia. Davis TP; Schoemaker H; Culling AJ; Yamamura HI Proc West Pharmacol Soc; 1983; 26():89-94. PubMed ID: 6310636 [No Abstract] [Full Text] [Related]
19. Isolation and characterization of in vitro endorphin metabolism in the brain. Davis TP; Schoemaker H; Chen A; Culling A; Yamamura HI Proc West Pharmacol Soc; 1982; 25():101-5. PubMed ID: 7122481 [No Abstract] [Full Text] [Related]
20. Withdrawal from endogenous opiates. Julius DA Am J Psychiatry; 1979 Mar; 136(3):358-9. PubMed ID: 420348 [No Abstract] [Full Text] [Related] [Next] [New Search]